Halozyme Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.36 |
Market Cap |
$2.52 B |
Shares Outstanding |
145.51 M |
Public Float |
129.63 M |
Address |
11388 Sorrento Valley Road San Diego California 92121 United States |
Employees | - |
Website | http://www.halozyme.com |
Updated | 07/08/2019 |
Halozyme Therapeutics, Inc. is a biopharmaceutical company specializes in research, development, and commercialization of human enzymes and other drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. |